{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,1,17]],"date-time":"2023-01-17T10:19:52Z","timestamp":1673950792550},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.thromres.2011.05.002","type":"journal-article","created":{"date-parts":[[2011,6,20]],"date-time":"2011-06-20T10:07:55Z","timestamp":1308564475000},"page":"417-421","source":"Crossref","is-referenced-by-count":3,"title":["Certoparin versus UFH to prevent venous thromboembolic events in the very elderly patient: An analysis of the CERTIFY study"],"prefix":"10.1016","volume":"128","author":[{"given":"S.M.","family":"Schellong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-E.","family":"Gerlach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Tebbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Haas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Melzer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Abletshauser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Sieder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Bramlage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Riess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2011.05.002_bb0005","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1001\/archinte.164.20.2260","article-title":"Venous thromboembolism according to age: the impact of an aging population","volume":"164","author":"Stein","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.05.002_bb0010","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1532-5415.2004.52359.x","article-title":"Risk factors for deep vein thrombosis in inpatients aged 65 and older: a case-control multicenter study","volume":"52","author":"Weill-Engerer","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.thromres.2011.05.002_bb0015","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/00001721-200306000-00004","article-title":"Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study","volume":"14","author":"Alikhan","year":"2003","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.thromres.2011.05.002_bb0020","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/j.1538-7836.2004.00842.x","article-title":"Challenges in the prevention of venous thromboembolism in the elderly","volume":"2","author":"Di Minno","year":"2004","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.05.002_bb0025","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ccl.2007.12.008","article-title":"Prevention of venous thromboembolism in the geriatric patient","volume":"26","author":"Brotman","year":"2008","journal-title":"Cardiol Clin"},{"key":"10.1016\/j.thromres.2011.05.002_bb0030","first-page":"165","article-title":"Use of anticoagulants in elderly patients: practical recommendations","volume":"4","author":"Robert-Ebadi","year":"2009","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.thromres.2011.05.002_bb0035","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1538-7836.2010.03848.x","article-title":"A randomized, double-blind, multicenter study of certoparin versus UFH to prevent venous thromboembolic events in acutely ill, non-surgical patients; The CERTIFY Study","volume":"8","author":"Riess","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.05.002_bb0040","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ahj.2010.10.005","article-title":"Certoparin versus unfractionated heparin to prevent venous thromboembolic events in patients hospitalized because of heart failure: A subgroup analysis of the randomized, controlled CERTIFY study","volume":"161","author":"Tebbe","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2011.05.002_bb0045","doi-asserted-by":"crossref","DOI":"10.1160\/TH10-09-0614","article-title":"CERTIFY: Prophylaxis of venous thromboembolism in patients with severe renal insufficiency","volume":"105","author":"Bauersachs","year":"2011","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.05.002_bb0050","first-page":"241","article-title":"Effectiveness of low molecular weight heparin (Fragmin) in the prevention of thromboembolism in internal medicine patients. A randomized double-blind study","volume":"83","author":"Poniewierski","year":"1988","journal-title":"Med Klin (Munich)"},{"key":"10.1016\/j.thromres.2011.05.002_bb0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/0049-3848(90)90422-9","article-title":"Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients","volume":"59","author":"Harenberg","year":"1990","journal-title":"Thromb Res"},{"key":"10.1016\/j.thromres.2011.05.002_bb0060","first-page":"127","article-title":"Subcutaneous low-molecular-weight heparin versus standard heparin and the prevention of thromboembolism in medical inpatients. The Heparin Study in Internal Medicine Group","volume":"26","author":"Harenberg","year":"1996","journal-title":"Haemostasis"},{"issue":"Suppl. 2","key":"10.1016\/j.thromres.2011.05.002_bb0065","first-page":"49","article-title":"The venous thrombotic risk in non-surgical patients: epidemiological data and efficacy\/safety profile of a low-molecular-weight heparin (enoxaparin). The Prime Study Group","volume":"26","author":"Lechler","year":"1996","journal-title":"Haemostasis"},{"key":"10.1016\/j.thromres.2011.05.002_bb0070","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1067\/mhj.2003.189","article-title":"Randomized comparison of enoxaparin with unfractionated heparin for the prevention of venous thromboembolism in medical patients with heart failure or severe respiratory disease","volume":"145","author":"Kleber","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.thromres.2011.05.002_bb0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1055\/s-0038-1650617","article-title":"A multicenter randomized double-blind study of enoxaparin compared with unfractionated heparin in the prevention of venous thromboembolic disease in elderly in-patients bedridden for an acute medical illness. The Enoxaparin in Medicine Study Group","volume":"76","author":"Bergmann","year":"1996","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.05.002_bb0080","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1055\/s-0037-1613391","article-title":"A safety analysis of thromboprophylaxis in acute medical illness","volume":"89","author":"Alikhan","year":"2003","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.05.002_bb0085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJM199909093411103","article-title":"A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group","volume":"341","author":"Samama","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.thromres.2011.05.002_bb0090","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1161\/01.CIR.0000138928.83266.24","article-title":"Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients","volume":"110","author":"Leizorovicz","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2011.05.002_bb0095","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archinte.165.3.341","article-title":"Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: a subgroup analysis of the PREVENT trial","volume":"165","author":"Kucher","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.05.002_bb0100","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/bmj.38733.466748.7C","article-title":"Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial","volume":"332","author":"Cohen","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.thromres.2011.05.002_bb0105","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(08)60202-0","article-title":"Venous thromboembolism risk and prophylaxis in the acute hospital care setting (ENDORSE study): a multinational cross-sectional study","volume":"371","author":"Cohen","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.thromres.2011.05.002_bb0110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0037-1613749","article-title":"Prevention of venous thromboembolism in internal medicine with unfractionated or low-molecular-weight heparins: a meta-analysis of randomised clinical trials","volume":"83","author":"Mismetti","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.thromres.2011.05.002_bb0115","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","article-title":"Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients","volume":"146","author":"Dentali","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.thromres.2011.05.002_bb0120","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1016\/j.clinthera.2007.11.015","article-title":"Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients","volume":"29","author":"Kanaan","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.thromres.2011.05.002_bb0125","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1001\/archinte.167.14.1476","article-title":"Pharmacological venous thromboembolism prophylaxis in hospitalized medical patients: a meta-analysis of randomized controlled trials","volume":"167","author":"Wein","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.thromres.2011.05.002_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1365-2796.2007.01878.x","article-title":"Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis","volume":"263","author":"Sjalander","year":"2008","journal-title":"J Intern Med"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811002271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384811002271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,12]],"date-time":"2019-06-12T01:53:27Z","timestamp":1560304407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384811002271"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0049384811002271"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2011.05.002","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}